These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 12513674)

  • 21. Alternatives to animal experimentation: the regulatory background.
    Garthoff B
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):388-92. PubMed ID: 15982684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of an integrated project (Sens-it-iv) to develop in vitro tests to assess sensitisation.
    Rovida C; Basketter D; Casati S; de Silva O; Hermans H; Kimber I; Manou I; Weltzien HU; Roggen E
    Altern Lab Anim; 2007 Jun; 35(3):317-22. PubMed ID: 17650950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Scientific basis of the OCRA method for risk assessment of biomechanical overload of upper limb, as preferred method in ISO standards on biomechanical risk factors.
    Colombini D; Occhipinti E
    Scand J Work Environ Health; 2018 Jul; 44(4):436-438. PubMed ID: 29961081
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-EEA doctors in EEA countries: doctors or cleaners?
    Herfs PG; Kater L; Haalboom JR
    Med Teach; 2007 May; 29(4):383-9. PubMed ID: 17786755
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Status of law-making on animal welfare].
    Polten B
    Dtsch Tierarztl Wochenschr; 2007 Mar; 114(3):98-103. PubMed ID: 17419542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Animal use in the safety evaluation of chemicals: harmonization and emerging needs.
    Spielmann H
    ILAR J; 2002; 43 Suppl():S11-7. PubMed ID: 12388845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Recent developments on the European ban on animal experiments for cosmetics].
    Ruhdel IW
    ALTEX; 2001; 18(1):13-6. PubMed ID: 11248844
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
    Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
    Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [White Paper of the European Commission--strategy for a new chemicals policy].
    Spielmann H
    ALTEX; 2002; 19 Suppl 1():20-5. PubMed ID: 12096326
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A critical assessment of the European Commission's proposals for the risk assessment and registration of chemical substances in the European Union.
    Combes R; Dandrea J; Balls M
    Altern Lab Anim; 2003; 31(3):353-64. PubMed ID: 15612876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. European Union implementation of Article 5.3 of the Framework Convention on Tobacco Control.
    Hawkins B; Holden C
    Global Health; 2018 Aug; 14(1):79. PubMed ID: 30071862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Introduction to the EU REACH legislation.
    Grindon C; Combes R
    Altern Lab Anim; 2006 Mar; 34 Suppl 1():5-10. PubMed ID: 16555955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alternative (non-animal) methods for cosmetics testing: current status and future prospects-2010.
    Adler S; Basketter D; Creton S; Pelkonen O; van Benthem J; Zuang V; Andersen KE; Angers-Loustau A; Aptula A; Bal-Price A; Benfenati E; Bernauer U; Bessems J; Bois FY; Boobis A; Brandon E; Bremer S; Broschard T; Casati S; Coecke S; Corvi R; Cronin M; Daston G; Dekant W; Felter S; Grignard E; Gundert-Remy U; Heinonen T; Kimber I; Kleinjans J; Komulainen H; Kreiling R; Kreysa J; Leite SB; Loizou G; Maxwell G; Mazzatorta P; Munn S; Pfuhler S; Phrakonkham P; Piersma A; Poth A; Prieto P; Repetto G; Rogiers V; Schoeters G; Schwarz M; Serafimova R; Tähti H; Testai E; van Delft J; van Loveren H; Vinken M; Worth A; Zaldivar JM
    Arch Toxicol; 2011 May; 85(5):367-485. PubMed ID: 21533817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new reductionism for animal research.
    Fisher C
    Altern Lab Anim; 1995; 23(3):318-31. PubMed ID: 11656568
    [No Abstract]   [Full Text] [Related]  

  • 35. [EU-Cosmetics: timetables for the replacement of animal experiments].
    Ruhdel IW
    ALTEX; 2005; 22(2):117-9. PubMed ID: 15953967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The ECVAM workshops: a critical assessment of their impact on the development, validation and acceptance of alternative methods.
    Combes RD
    Altern Lab Anim; 2002 Dec; 30 Suppl 2():151-65. PubMed ID: 12513668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preferences on policy options for ensuring the financial sustainability of health care services in the future: results of a stakeholder survey.
    Tordrup D; Angelis A; Kanavos P
    Appl Health Econ Health Policy; 2013 Dec; 11(6):639-52. PubMed ID: 24129648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The 3Rs in animal welfare bodies at Swedish universities - knowledge, attitudes, implementation.
    Lindsjö J; Berg C; Olsson U; Törnqvist E
    ALTEX; 2021; 38(3):477-489. PubMed ID: 33786636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Global Health Policies of the EU and its Member States: A Common Vision?
    Steurs L; Van de Pas R; Delputte S; Orbie J
    Int J Health Policy Manag; 2018 May; 7(5):433-442. PubMed ID: 29764107
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ECVAM'S activities in the EU candidate countries.
    Sladowski D; Halder M
    Altern Lab Anim; 2002 Dec; 30 Suppl 2():203-5. PubMed ID: 12513675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.